Literature DB >> 12354577

Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.

Vera Ralevic1, David A Kendall, Michael D Randall, Darren Smart.   

Abstract

Capsaicin-sensitive sensory nerves are widely distributed in the cardiovascular system. They are activated by a variety of physical and chemical stimuli, characteristically by capsaicin acting via the vanilloid receptor VR1, and have a role in the regulation of peripheral vascular resistance and maintenance of homeostasis via their afferent and efferent functions. Cannabinoids, a recently discovered family of extracellular signalling molecules, can act at cannabinoid (CB) receptors expressed on sensory nerves, to cause inhibition of sensory neurotransmitter release. There is recent evidence, however, that anandamide, an endogenous cannabinoid, can activate VR1, coexpressed with CB receptors on the same sensory nerve terminals, causing a release of sensory neurotransmitter, vasorelaxation and hypotension. Hence, anandamide can elicit opposite actions, inhibition via CB receptors and excitation via VR1, on sensory neurotransmission. The possible biological significance of this is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354577     DOI: 10.1016/s0024-3205(02)02086-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.

Authors:  M Domenicali; J Ros; G Fernández-Varo; P Cejudo-Martín; M Crespo; M Morales-Ruiz; A M Briones; J-M Campistol; V Arroyo; E Vila; J Rodés; W Jiménez
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 3.  [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].

Authors:  U Schneider; J Seifert; M Karst; J Schlimme; K Cimander; K R Müller-Vahl
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 4.  Targeted lipidomics: discovery of new fatty acyl amides.

Authors:  Bo Tan; Heather B Bradshaw; Neta Rimmerman; Harini Srinivasan; Y William Yu; Jocelyn F Krey; M Francesca Monn; Jay Shih-Chieh Chen; Sherry Shu-Jung Hu; Sarah R Pickens; J Michael Walker
Journal:  AAPS J       Date:  2006-07-14       Impact factor: 4.009

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 6.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

7.  Electrophysiological effects of anandamide on rat myocardium.

Authors:  Qian Li; Hui-Jie Ma; Hao Zhang; Zhao Qi; Yue Guan; Yi Zhang
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 8.  The emerging role of the endocannabinoid system in cardiovascular disease.

Authors:  Pál Pacher; Sabine Steffens
Journal:  Semin Immunopathol       Date:  2009-04-09       Impact factor: 9.623

9.  Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.

Authors:  E Herradón; M I Martín; V López-Miranda
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

10.  The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor.

Authors:  Maurice A Williams; Scott A Smith; Daniel E O'Brien; Jere H Mitchell; Mary G Garry
Journal:  J Physiol       Date:  2007-12-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.